G71.0342
Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction
Clinical Classification Guidelines
Inclusion Terms
- Beta sarcoglycanopathy
- Limb girdle muscular dystrophy due to beta-sarcoglycan deficiency
- Limb girdle muscular dystrophy type 2E
Medical Intelligence & Overview
Limb girdle muscular dystrophy due to beta-sarcoglycan dysfunction is a genetic condition that primarily affects the muscles around the hips and shoulders. Also known as limb girdle muscular dystrophy type 2E, this disorder results from a deficiency or malfunction of the beta-sarcoglycan protein, which is vital for muscle fiber stability. Over time, individuals may experience progressive muscle weakness and loss, impacting mobility and quality of life.
Causes & Symptoms
Clinical Causes: Genetic mutations in the SGCB gene that encodes the beta-sarcoglycan protein Inheritance patterns typically autosomal recessive, meaning a person must inherit two copies of the mutated gene to develop the condition No known environmental or lifestyle factors directly cause the disorder
Key Symptoms: Progressive weakness in the muscles of the hips and shoulders Difficulty walking or running as leg muscles weaken Frequent stumbling or falls Muscle wasting or atrophy Potential involvement of other muscles leading to difficulties with movements In some cases, cardiac or respiratory muscles may be affected, leading to further health concerns
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, family history, and specialized tests. These include genetic testing to identify mutations in the SGCB gene, blood tests to measure muscle enzymes such as creatine kinase, electromyography (EMG) to assess muscle electrical activity, and muscle biopsy to examine tissue under a microscope for characteristic changes. Confirmation of beta-sarcoglycan deficiency is critical for an accurate diagnosis.
Treatment Protocols: Currently, there is no cure for limb girdle muscular dystrophy due to beta-sarcoglycan dysfunction. Treatment strategies focus on managing symptoms, improving quality of life, and preventing complications. These may include physical therapy to maintain muscle strength and flexibility, occupational therapy for daily activities, respiratory support if breathing becomes affected, and addressing cardiac issues if present. Regular monitoring and supportive care are essential components of managing the condition.
Clinical Advice & FAQs
Billing Guidance
Is G71.0342 a billable ICD-10 code?
Yes, G71.0342 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.0342?
Clinical documentation must specify the nature of Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference